These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7883388)

  • 21. Biapenem versus imipenem/cilastatin in the treatment of complicated intra-abdominal infections: report from a Swedish Study Group.
    Brismar B; Akerlund JE; Sjöstedt S; Johansson C; Törnqvist A; Bäckstrand B; Bång H; Andåker L; Gustafsson PO; Darle N; Angerås M; Falk A; Tunevall G; Kasholm-Tengve B; Skau T; Nyström PO; Gasslander T; Hagelbäck A; Olsson-Liljequist B; Eklund AE; Nord CE
    Scand J Infect Dis; 1996; 28(5):507-12. PubMed ID: 8953683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjunctive antimicrobials in surgery of soft tissue infections: evaluation of cephalosporins and carbapenems.
    Lami JL; Wilson SE; Hopkins JA
    Am Surg; 1991 Dec; 57(12):769-74. PubMed ID: 1746792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulary review of the carbapenems: comparison of imipenem/cilastatin and meropenem.
    Richerson MA; Ambrose PG; Quintiliani R; Nightingale CH
    Conn Med; 1998 Mar; 62(3):165-9. PubMed ID: 9573653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
    Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
    Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safe use of meropenem in a patient with a possible nonimmediate allergy to imipenem.
    Lakhal K; Lortat-Jacob B; Neukirch C; Pajot O; Wolff M
    Pharmacotherapy; 2007 Sep; 27(9):1334-8. PubMed ID: 17723087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pyogenic hepatic abscess. Review of 59 cases and experience with imipenem].
    Asensi Alvarez V; Rodríguez-Guardado A; Carton Sánchez JA; Maradona Hidalgo JA; Alvarez-Prida de Paz E; Llera Fueyo JM; Arribas Castrillo JM
    Rev Clin Esp; 1997 Jul; 197(7):494-9. PubMed ID: 9411546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on the efficacy and tolerability of meropenem in the treatment of serious bacterial infections.
    Mohr JF
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S41-51. PubMed ID: 18713049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy.
    Romanelli G; Cravarezza P; Pozzi A; Franchino L; Ravizzola G; Zulli R; Donati P; Prometti P; Grassi V
    J Chemother; 2002 Dec; 14(6):609-17. PubMed ID: 12583553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intramuscular meropenem in the treatment of bacterial infections of the urinary and lower respiratory tracts. Italian Intramuscular Meropenem Study Group.
    Romanelli G; Cravarezza P
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():109-19. PubMed ID: 8543487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy of imipenem-cilastatin in combined therapy of severe anaerobic-aerobic infection of bones and soft tissues].
    Goriunov SV; Romashov DV; Butivshchenko IA; Il'ianina AA; Mikhal'skiĭ VV; Rog AA; Polikarpova SV
    Khirurgiia (Mosk); 2002; (7):50-6. PubMed ID: 12162087
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of Bacteroides fragilis in the pathogenesis of acute appendicitis.
    Pieper R; Kager L; Weintraub A; Lindberg AA; Nord CE
    Acta Chir Scand; 1982; 148(1):39-44. PubMed ID: 7136410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of ciprofloxacin in the treatment of hospitalized patients with intra-abdominal infections.
    Madan AK
    Clin Ther; 2004 Oct; 26(10):1564-77. PubMed ID: 15598473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
    Garbino J; Villiger P; Caviezel A; Matulionyte R; Uckay I; Morel P; Lew D
    Infection; 2007 Jun; 35(3):161-6. PubMed ID: 17565457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
    Caldwell JW; Singh S; Johnson RH
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():129-34. PubMed ID: 10225583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data.
    Babinchak T; Ellis-Grosse E; Dartois N; Rose GM; Loh E; ;
    Clin Infect Dis; 2005 Sep; 41 Suppl 5():S354-67. PubMed ID: 16080073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of a novel carbapenem, doripenem, against anaerobic pathogens.
    Goldstein EJ; Citron DM
    Diagn Microbiol Infect Dis; 2009 Apr; 63(4):447-54. PubMed ID: 19249176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacteriology and antibiotic susceptibility of community-acquired intra-abdominal infection in children.
    Lin WJ; Lo WT; Chu CC; Chu ML; Wang CC
    J Microbiol Immunol Infect; 2006 Jun; 39(3):249-54. PubMed ID: 16783457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meropenem (1.5 g/day) is as effective as imipenem/cilastatin (2 g/day) for the treatment of moderately severe intra-abdominal infections.
    Zanetti G; Harbarth SJ; Trampuz A; Ganeo M; Mosimann F; Chautemps R; Morel P; Lew D; Zimmerli W; Lange J; Glauser M
    Int J Antimicrob Agents; 1999 Feb; 11(2):107-13. PubMed ID: 10221413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Empiric treatment of nosocomial intra-abdominal infections: a focus on the carbapenems.
    Tellado JM; Wilson SE
    Surg Infect (Larchmt); 2005; 6(3):329-43. PubMed ID: 16201943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness study of imipenem/cilastatin versus meropenem in intra-abdominal infections.
    Attanasio E; Russo P; Carunchio G; Basoli A; Caprino L
    Dig Surg; 2000; 17(2):164-72. PubMed ID: 10781982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.